| 0 |
ENDOMETRIAL SARCOMA METASTATIC |
1 |
0.2500 |
| 1 |
STAPHYLOCOCCAL MEDIASTINITIS |
4 |
0.1818 |
| 2 |
ENCEPHALITIS POST MEASLES |
1 |
0.1667 |
| 3 |
DIFFUSE CUTANEOUS MASTOCYTOSIS |
5 |
0.1667 |
| 4 |
MYOCARDITIS TOXOPLASMAL |
2 |
0.1176 |
| 5 |
SEROCONVERSION TEST POSITIVE |
6 |
0.1132 |
| 6 |
LICHEN STRIATUS |
1 |
0.0667 |
| 7 |
EVAN'S SYNDROME |
1 |
0.0588 |
| 8 |
CONGENITAL DYSKERATOSIS |
1 |
0.0526 |
| 9 |
GRAM STAIN NEGATIVE |
1 |
0.0526 |
| 10 |
CENTRAL HYPOTHYROIDISM |
13 |
0.0393 |
| 11 |
CD8 LYMPHOCYTES INCREASED |
2 |
0.0323 |
| 12 |
NON-HODGKIN'S LYMPHOMA STAGE IV |
1 |
0.0323 |
| 13 |
NECROTISING GASTRITIS |
1 |
0.0312 |
| 14 |
MYOCARDITIS BACTERIAL |
1 |
0.0303 |
| 15 |
CLONAL EVOLUTION |
3 |
0.0288 |
| 16 |
GINGIVECTOMY |
1 |
0.0286 |
| 17 |
HEMISENSORY NEGLECT |
1 |
0.0286 |
| 18 |
HEPATIC NEOPLASM MALIGNANT RECURRENT |
3 |
0.0283 |
| 19 |
CSF LYMPHOCYTE COUNT ABNORMAL |
1 |
0.0278 |
| 20 |
EPSTEIN-BARR VIRUS ANTIGEN POSITIVE |
3 |
0.0259 |
| 21 |
NEONATAL MULTI-ORGAN FAILURE |
1 |
0.0200 |
| 22 |
PRIMARY HYPOGONADISM |
3 |
0.0191 |
| 23 |
VIRAL HAEMORRHAGIC CYSTITIS |
13 |
0.0183 |
| 24 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
6 |
0.0166 |
| 25 |
HAEMORRHAGIC PNEUMONIA |
1 |
0.0161 |
| 26 |
GLOMERULONEPHRITIS FOCAL |
1 |
0.0159 |
| 27 |
CARDIAC PSEUDOANEURYSM |
1 |
0.0145 |
| 28 |
COLD AGGLUTININS POSITIVE |
1 |
0.0143 |
| 29 |
POLYOMAVIRUS VIRAEMIA |
15 |
0.0141 |
| 30 |
BACTERIAL CULTURE POSITIVE |
1 |
0.0141 |
| 31 |
HEPATOSPLENIC CANDIDIASIS |
2 |
0.0136 |
| 32 |
CYTOMEGALOVIRUS OESOPHAGITIS |
5 |
0.0136 |
| 33 |
ANTI-THYROID ANTIBODY |
1 |
0.0133 |
| 34 |
ALLERGIC TRANSFUSION REACTION |
2 |
0.0132 |
| 35 |
FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM |
1 |
0.0132 |
| 36 |
BLOOD BRAIN BARRIER DEFECT |
2 |
0.0132 |
| 37 |
TRANSPLANT DYSFUNCTION |
23 |
0.0129 |
| 38 |
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
6 |
0.0128 |
| 39 |
SERUM SICKNESS |
35 |
0.0125 |
| 40 |
ABDOMINAL WALL ANOMALY |
1 |
0.0112 |
| 41 |
HAEMOSIDEROSIS |
3 |
0.0112 |
| 42 |
DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION |
4 |
0.0110 |
| 43 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
2 |
0.0109 |
| 44 |
MEGAKARYOCYTES DECREASED |
1 |
0.0108 |
| 45 |
AEROMONAS INFECTION |
2 |
0.0106 |
| 46 |
ENGRAFT FAILURE |
3 |
0.0105 |
| 47 |
HEPATITIS INFECTIOUS MONONUCLEOSIS |
1 |
0.0103 |
| 48 |
MASTOID DISORDER |
1 |
0.0101 |
| 49 |
JEJUNAL ULCER |
2 |
0.0099 |
| 50 |
RETICULOCYTE COUNT INCREASED |
8 |
0.0099 |
| 51 |
POST TRANSPLANT DISTAL LIMB SYNDROME |
2 |
0.0099 |
| 52 |
PNEUMOCYSTIS CARINII PNEUMONIA |
2 |
0.0099 |
| 53 |
SODIUM RETENTION |
2 |
0.0098 |
| 54 |
APOPTOSIS |
3 |
0.0097 |
| 55 |
PERICARDITIS CONSTRICTIVE |
4 |
0.0095 |
| 56 |
FOCAL GLOMERULOSCLEROSIS |
1 |
0.0094 |
| 57 |
MUCOCUTANEOUS ULCERATION |
2 |
0.0088 |
| 58 |
LUMBAR PUNCTURE ABNORMAL |
1 |
0.0086 |
| 59 |
CD4 LYMPHOCYTES INCREASED |
2 |
0.0086 |
| 60 |
GRAFT VERSUS HOST DISEASE IN LIVER |
6 |
0.0084 |
| 61 |
DISSEMINATED TOXOPLASMOSIS |
1 |
0.0083 |
| 62 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
2 |
0.0082 |
| 63 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
7 |
0.0076 |
| 64 |
OSTEOMYELITIS BACTERIAL |
2 |
0.0073 |
| 65 |
DUODENITIS HAEMORRHAGIC |
1 |
0.0072 |
| 66 |
CRANIAL NERVE PALSIES MULTIPLE |
1 |
0.0071 |
| 67 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
5 |
0.0070 |
| 68 |
ENDOMETRIAL ATROPHY |
1 |
0.0069 |
| 69 |
RENAL TUBULAR ATROPHY |
6 |
0.0068 |
| 70 |
ENGRAFTMENT SYNDROME |
4 |
0.0068 |
| 71 |
ERYTHROSIS |
1 |
0.0066 |
| 72 |
MYCOPLASMA TEST POSITIVE |
1 |
0.0066 |
| 73 |
ENTEROCOLITIS VIRAL |
2 |
0.0066 |
| 74 |
DONOR SPECIFIC ANTIBODY PRESENT |
1 |
0.0065 |
| 75 |
SKIN TEST POSITIVE |
6 |
0.0064 |
| 76 |
ZYGOMYCOSIS |
3 |
0.0064 |
| 77 |
GASTROENTERITIS ADENOVIRUS |
1 |
0.0064 |
| 78 |
CHROMOSOMAL DELETION |
1 |
0.0063 |
| 79 |
CAPILLARY LEAK SYNDROME |
13 |
0.0063 |
| 80 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
2 |
0.0062 |
| 81 |
MEDIASTINAL HAEMATOMA |
1 |
0.0060 |
| 82 |
CYSTITIS KLEBSIELLA |
1 |
0.0060 |
| 83 |
RENAL TUBULAR INJURY |
7 |
0.0058 |
| 84 |
BONE MARROW MYELOGRAM ABNORMAL |
1 |
0.0057 |
| 85 |
ENCEPHALITIS VIRAL |
7 |
0.0057 |
| 86 |
GRAFT VERSUS HOST DISEASE |
41 |
0.0057 |
| 87 |
COMPLEMENT FACTOR DECREASED |
1 |
0.0056 |
| 88 |
GRAFT LOSS |
4 |
0.0055 |
| 89 |
BLOOD ZINC DECREASED |
1 |
0.0055 |
| 90 |
EPSTEIN-BARR VIRAEMIA |
6 |
0.0054 |
| 91 |
VIRAL MYOCARDITIS |
2 |
0.0053 |
| 92 |
CYSTITIS VIRAL |
2 |
0.0052 |
| 93 |
COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL |
1 |
0.0052 |
| 94 |
COOMBS NEGATIVE HAEMOLYTIC ANAEMIA |
1 |
0.0051 |
| 95 |
EPSTEIN-BARR VIRUS ANTIBODY POSITIVE |
2 |
0.0051 |
| 96 |
HYPERTENSIVE ENCEPHALOPATHY |
3 |
0.0051 |
| 97 |
TRANSPLANT REJECTION |
40 |
0.0050 |
| 98 |
APLASTIC ANAEMIA |
26 |
0.0050 |
| 99 |
EPSTEIN-BARR VIRUS INFECTION |
31 |
0.0050 |
| 100 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
7 |
0.0050 |
| 101 |
GASTROENTERITIS CRYPTOSPORIDIAL |
1 |
0.0049 |
| 102 |
MUSCLE ABSCESS |
3 |
0.0048 |
| 103 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0048 |
| 104 |
HUMAN HERPESVIRUS 6 INFECTION |
9 |
0.0048 |
| 105 |
APPARENT LIFE THREATENING EVENT |
2 |
0.0047 |
| 106 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
13 |
0.0047 |
| 107 |
POLYSEROSITIS |
2 |
0.0047 |
| 108 |
BLOOD STEM CELL TRANSPLANT FAILURE |
1 |
0.0047 |
| 109 |
CYTOMEGALOVIRUS GASTROENTERITIS |
1 |
0.0046 |
| 110 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
1 |
0.0046 |
| 111 |
LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED |
1 |
0.0046 |
| 112 |
MILLER FISHER SYNDROME |
1 |
0.0045 |
| 113 |
GRAFT VERSUS HOST DISEASE IN EYE |
1 |
0.0043 |
| 114 |
MUCOSAL INFECTION |
1 |
0.0043 |
| 115 |
ADENOVIRAL HEPATITIS |
1 |
0.0043 |
| 116 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
9 |
0.0042 |
| 117 |
LYMPHOPROLIFERATIVE DISORDER |
12 |
0.0041 |
| 118 |
CYTOMEGALOVIRUS VIRAEMIA |
18 |
0.0040 |
| 119 |
MENINGORRHAGIA |
1 |
0.0040 |
| 120 |
INTUBATION |
1 |
0.0040 |
| 121 |
ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE |
1 |
0.0040 |
| 122 |
FUNGAL PHARYNGITIS |
1 |
0.0040 |
| 123 |
METASTASES TO THORAX |
1 |
0.0040 |
| 124 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
1 |
0.0039 |
| 125 |
GLOMERULONEPHROPATHY |
1 |
0.0039 |
| 126 |
BONE MARROW RETICULIN FIBROSIS |
1 |
0.0039 |
| 127 |
GRAFT THROMBOSIS |
1 |
0.0038 |
| 128 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
5 |
0.0038 |
| 129 |
URTICARIAL VASCULITIS |
2 |
0.0038 |
| 130 |
HYPOALDOSTERONISM |
1 |
0.0036 |
| 131 |
CENTRAL NERVOUS SYSTEM NECROSIS |
1 |
0.0036 |
| 132 |
GRAFT VERSUS HOST DISEASE IN SKIN |
8 |
0.0036 |
| 133 |
ENTEROCOLITIS BACTERIAL |
1 |
0.0036 |
| 134 |
CHRONIC GRAFT VERSUS HOST DISEASE |
13 |
0.0036 |
| 135 |
CHEMICAL BURNS OF EYE |
1 |
0.0036 |
| 136 |
GRAFT DYSFUNCTION |
1 |
0.0035 |
| 137 |
T-CELL LYMPHOMA |
4 |
0.0035 |
| 138 |
ROTAVIRUS INFECTION |
2 |
0.0035 |
| 139 |
KIDNEY FIBROSIS |
6 |
0.0035 |
| 140 |
HYPOURICAEMIA |
1 |
0.0034 |
| 141 |
METAL POISONING |
2 |
0.0034 |
| 142 |
SYSTEMIC MYCOSIS |
4 |
0.0034 |
| 143 |
HEPATIC ARTERY THROMBOSIS |
1 |
0.0034 |
| 144 |
GRAFT COMPLICATION |
2 |
0.0034 |
| 145 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
1 |
0.0034 |
| 146 |
GINGIVAL HYPERPLASIA |
2 |
0.0033 |
| 147 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
17 |
0.0033 |
| 148 |
ENTEROBACTER BACTERAEMIA |
1 |
0.0033 |
| 149 |
GINGIVAL HYPERTROPHY |
5 |
0.0033 |
| 150 |
BLOOD BETA-D-GLUCAN INCREASED |
1 |
0.0033 |
| 151 |
OSTEOMYELITIS CHRONIC |
2 |
0.0032 |
| 152 |
CONGENITAL APLASIA |
1 |
0.0032 |
| 153 |
COOMBS DIRECT TEST POSITIVE |
1 |
0.0032 |
| 154 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
2 |
0.0032 |
| 155 |
EYE INFECTION VIRAL |
1 |
0.0031 |
| 156 |
ADENOVIRUS INFECTION |
9 |
0.0031 |
| 157 |
BONE MARROW DEPRESSION |
3 |
0.0031 |
| 158 |
BLOOD CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0030 |
| 159 |
HISTIOCYTOSIS HAEMATOPHAGIC |
9 |
0.0030 |
| 160 |
INFUSION SITE REACTION |
9 |
0.0030 |
| 161 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
7 |
0.0030 |
| 162 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
13 |
0.0029 |
| 163 |
GIARDIASIS |
1 |
0.0029 |
| 164 |
ORAL FUNGAL INFECTION |
8 |
0.0029 |
| 165 |
TRANSPLANT FAILURE |
7 |
0.0029 |
| 166 |
PSEUDOMONAL SEPSIS |
5 |
0.0029 |
| 167 |
FUNGAL TEST POSITIVE |
1 |
0.0028 |
| 168 |
VENOOCCLUSIVE LIVER DISEASE |
14 |
0.0028 |
| 169 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
5 |
0.0028 |
| 170 |
COMPLICATIONS OF TRANSPLANTED LIVER |
1 |
0.0028 |
| 171 |
PULMONARY SEPSIS |
4 |
0.0027 |
| 172 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0027 |
| 173 |
MEDIASTINAL DISORDER |
1 |
0.0027 |
| 174 |
BK VIRUS INFECTION |
9 |
0.0027 |
| 175 |
STEROID DIABETES |
4 |
0.0027 |
| 176 |
NON-CIRRHOTIC PORTAL HYPERTENSION |
1 |
0.0027 |
| 177 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 178 |
AMYOTROPHY |
1 |
0.0026 |
| 179 |
CRITICAL ILLNESS |
2 |
0.0026 |
| 180 |
BREAKTHROUGH HAEMOLYSIS |
1 |
0.0025 |
| 181 |
HEPATITIS VIRAL |
2 |
0.0025 |
| 182 |
CAT SCRATCH DISEASE |
1 |
0.0025 |
| 183 |
BLEEDING TIME PROLONGED |
3 |
0.0025 |
| 184 |
HAPTOGLOBIN DECREASED |
2 |
0.0025 |
| 185 |
SIMPLE PARTIAL SEIZURES |
2 |
0.0025 |
| 186 |
LYMPHOCYTE PERCENTAGE INCREASED |
1 |
0.0025 |
| 187 |
BACTERIAL SEPSIS |
8 |
0.0025 |
| 188 |
SYSTEMIC INFECTION |
4 |
0.0024 |
| 189 |
ACUTE GRAFT VERSUS HOST DISEASE |
11 |
0.0024 |
| 190 |
STEM CELL TRANSPLANT |
6 |
0.0024 |
| 191 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 192 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
1 |
0.0024 |
| 193 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 194 |
HYPERFERRITINAEMIA |
1 |
0.0023 |
| 195 |
AUTOIMMUNE THROMBOCYTOPENIA |
1 |
0.0023 |
| 196 |
OVARIAN CYST |
23 |
0.0023 |
| 197 |
ASPERGILLOSIS |
3 |
0.0023 |
| 198 |
ENCEPHALITIS CYTOMEGALOVIRUS |
1 |
0.0023 |
| 199 |
OPERATIVE HAEMORRHAGE |
1 |
0.0022 |
| 200 |
PARVOVIRUS B19 INFECTION |
2 |
0.0022 |
| 201 |
MENINGOENCEPHALITIS HERPETIC |
1 |
0.0022 |
| 202 |
HYPERPLASIA |
2 |
0.0022 |
| 203 |
NEUROSIS |
1 |
0.0022 |
| 204 |
URETERIC OBSTRUCTION |
3 |
0.0022 |
| 205 |
MUCOSAL EROSION |
2 |
0.0022 |
| 206 |
ANTI-THYROID ANTIBODY POSITIVE |
1 |
0.0022 |
| 207 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
1 |
0.0022 |
| 208 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
2 |
0.0022 |
| 209 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
14 |
0.0022 |
| 210 |
DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION |
1 |
0.0021 |
| 211 |
BASEDOW'S DISEASE |
1 |
0.0021 |
| 212 |
BONE MARROW TRANSPLANT |
4 |
0.0021 |
| 213 |
LACRIMATION DECREASED |
1 |
0.0021 |
| 214 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
0.0021 |
| 215 |
EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER |
1 |
0.0020 |
| 216 |
EVANS SYNDROME |
1 |
0.0020 |
| 217 |
CELL DEATH |
4 |
0.0020 |
| 218 |
VENOOCCLUSIVE DISEASE |
5 |
0.0020 |
| 219 |
KAPOSI'S SARCOMA |
1 |
0.0020 |
| 220 |
CSF TEST ABNORMAL |
1 |
0.0020 |
| 221 |
CATHETER RELATED INFECTION |
2 |
0.0020 |
| 222 |
PARAINFLUENZAE VIRUS INFECTION |
3 |
0.0020 |
| 223 |
CYTOMEGALOVIRUS INFECTION |
32 |
0.0019 |
| 224 |
FAECAL VOLUME INCREASED |
1 |
0.0019 |
| 225 |
NEUTROPHIL PERCENTAGE DECREASED |
1 |
0.0019 |
| 226 |
IRON OVERLOAD |
2 |
0.0019 |
| 227 |
TOXOPLASMOSIS |
2 |
0.0019 |
| 228 |
B-CELL LYMPHOMA RECURRENT |
1 |
0.0018 |
| 229 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
4 |
0.0018 |
| 230 |
LUNG CONSOLIDATION |
5 |
0.0018 |
| 231 |
INTRAVASCULAR HAEMOLYSIS |
1 |
0.0018 |
| 232 |
HAEMOGLOBINURIA |
2 |
0.0018 |
| 233 |
LIFE SUPPORT |
1 |
0.0018 |
| 234 |
INTRACRANIAL HAEMATOMA |
1 |
0.0018 |
| 235 |
HEPATIC FIBROSIS |
6 |
0.0017 |
| 236 |
APLASIA PURE RED CELL |
6 |
0.0017 |
| 237 |
MEDIASTINITIS |
1 |
0.0017 |
| 238 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 239 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
2 |
0.0017 |
| 240 |
KIDNEY TRANSPLANT REJECTION |
8 |
0.0017 |
| 241 |
MEAN PLATELET VOLUME INCREASED |
1 |
0.0017 |
| 242 |
CEREBRAL VENOUS THROMBOSIS |
3 |
0.0017 |
| 243 |
PNEUMONIA KLEBSIELLA |
3 |
0.0016 |
| 244 |
BACILLUS INFECTION |
1 |
0.0016 |
| 245 |
INTESTINAL FUNCTIONAL DISORDER |
1 |
0.0016 |
| 246 |
BRAIN ABSCESS |
4 |
0.0016 |
| 247 |
NOCARDIOSIS |
4 |
0.0016 |
| 248 |
HEPATOSPLENOMEGALY |
4 |
0.0016 |
| 249 |
THROMBOTIC MICROANGIOPATHY |
15 |
0.0015 |
| 250 |
FASCIITIS |
1 |
0.0015 |
| 251 |
PNEUMONIA FUNGAL |
6 |
0.0015 |
| 252 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0015 |
| 253 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
5 |
0.0015 |
| 254 |
STENOTROPHOMONAS INFECTION |
2 |
0.0015 |
| 255 |
MARROW HYPERPLASIA |
1 |
0.0015 |
| 256 |
CYTOKINE STORM |
1 |
0.0015 |
| 257 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 258 |
HAEMORRHAGIC CEREBRAL INFARCTION |
1 |
0.0014 |
| 259 |
DRUG TOLERANCE DECREASED |
4 |
0.0014 |
| 260 |
STAPHYLOCOCCUS TEST POSITIVE |
3 |
0.0014 |
| 261 |
BRONCHOPULMONARY ASPERGILLOSIS |
11 |
0.0014 |
| 262 |
FEBRILE BONE MARROW APLASIA |
6 |
0.0014 |
| 263 |
DELAYED GRAFT FUNCTION |
1 |
0.0014 |
| 264 |
MENINGITIS BACTERIAL |
2 |
0.0014 |
| 265 |
RENAL INFARCT |
2 |
0.0014 |
| 266 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 267 |
GENERALISED OEDEMA |
17 |
0.0014 |
| 268 |
ASPERGILLUS INFECTION |
9 |
0.0014 |
| 269 |
SKIN MASS |
9 |
0.0013 |
| 270 |
MYOCLONIC EPILEPSY |
2 |
0.0013 |
| 271 |
CHEST X-RAY ABNORMAL |
4 |
0.0013 |
| 272 |
PNEUMONIA PSEUDOMONAL |
2 |
0.0013 |
| 273 |
DEBRIDEMENT |
1 |
0.0013 |
| 274 |
EXTRADURAL ABSCESS |
1 |
0.0013 |
| 275 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
1 |
0.0013 |
| 276 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 277 |
ELECTROMECHANICAL DISSOCIATION |
1 |
0.0013 |
| 278 |
ENTEROCOCCAL INFECTION |
6 |
0.0012 |
| 279 |
CYSTITIS HAEMORRHAGIC |
5 |
0.0012 |
| 280 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
1 |
0.0012 |
| 281 |
FUNGAL SEPSIS |
1 |
0.0012 |
| 282 |
TROPONIN I INCREASED |
2 |
0.0012 |
| 283 |
SYSTEMIC CANDIDA |
3 |
0.0012 |
| 284 |
ENTEROBACTER INFECTION |
2 |
0.0012 |
| 285 |
SPINAL DEFORMITY |
2 |
0.0012 |
| 286 |
AMAUROSIS |
1 |
0.0012 |
| 287 |
LEUKAEMIA RECURRENT |
2 |
0.0012 |
| 288 |
APTYALISM |
1 |
0.0012 |
| 289 |
COLONIC ABSCESS |
1 |
0.0012 |
| 290 |
DIFFUSE LARGE B-CELL LYMPHOMA |
9 |
0.0012 |
| 291 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 292 |
MUCORMYCOSIS |
3 |
0.0012 |
| 293 |
HAEMOLYTIC ANAEMIA |
10 |
0.0011 |
| 294 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 295 |
BLOOD MAGNESIUM INCREASED |
1 |
0.0011 |
| 296 |
MULTI-ORGAN FAILURE |
19 |
0.0011 |
| 297 |
BACTERAEMIA |
13 |
0.0011 |
| 298 |
ANEURYSM RUPTURED |
1 |
0.0011 |
| 299 |
EXTENSOR PLANTAR RESPONSE |
1 |
0.0011 |
| 300 |
HAEMOCHROMATOSIS |
1 |
0.0011 |
| 301 |
OPPORTUNISTIC INFECTION |
2 |
0.0011 |
| 302 |
HYPERTRICHOSIS |
2 |
0.0011 |
| 303 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 304 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 305 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 306 |
ESCHERICHIA SEPSIS |
3 |
0.0010 |
| 307 |
LIVER FUNCTION TEST ABNORMAL |
30 |
0.0010 |
| 308 |
STAPHYLOCOCCAL SEPSIS |
5 |
0.0010 |
| 309 |
ENCEPHALITIS |
7 |
0.0010 |
| 310 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
16 |
0.0010 |
| 311 |
CEREBRAL ATROPHY |
4 |
0.0010 |
| 312 |
CANDIDIASIS |
4 |
0.0010 |
| 313 |
LYMPHOCYTIC INFILTRATION |
1 |
0.0010 |
| 314 |
RENAL HAEMORRHAGE |
2 |
0.0010 |
| 315 |
BRAIN STEM INFARCTION |
1 |
0.0010 |
| 316 |
HEART TRANSPLANT REJECTION |
1 |
0.0010 |
| 317 |
SKIN NECROSIS |
5 |
0.0010 |
| 318 |
ENTEROCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 319 |
PSEUDOMONAS INFECTION |
8 |
0.0009 |
| 320 |
FACIAL PALSY |
2 |
0.0009 |
| 321 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 322 |
HAEMORRHAGIC DISORDER |
1 |
0.0009 |
| 323 |
SEPTIC SHOCK |
40 |
0.0009 |
| 324 |
KIDNEY ENLARGEMENT |
1 |
0.0009 |
| 325 |
HEPATOCELLULAR INJURY |
13 |
0.0009 |
| 326 |
NOSOCOMIAL INFECTION |
2 |
0.0009 |
| 327 |
CLOSTRIDIUM TEST POSITIVE |
2 |
0.0009 |
| 328 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
1 |
0.0009 |
| 329 |
PULMONARY ALVEOLAR HAEMORRHAGE |
5 |
0.0009 |
| 330 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 331 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 332 |
HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0009 |
| 333 |
DILATATION ATRIAL |
1 |
0.0009 |
| 334 |
BLOOD BILIRUBIN INCREASED |
23 |
0.0009 |
| 335 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 336 |
MYOPIA |
2 |
0.0008 |
| 337 |
DYSPLASIA |
1 |
0.0008 |
| 338 |
BLOOD IMMUNOGLOBULIN G INCREASED |
1 |
0.0008 |
| 339 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 340 |
GLOMERULONEPHRITIS |
2 |
0.0008 |
| 341 |
HAEMATOCRIT ABNORMAL |
1 |
0.0008 |
| 342 |
BENIGN INTRACRANIAL HYPERTENSION |
1 |
0.0008 |
| 343 |
TOXIC SKIN ERUPTION |
8 |
0.0008 |
| 344 |
HYPERTHERMIA |
6 |
0.0008 |
| 345 |
HEPATIC CYTOLYSIS |
10 |
0.0008 |
| 346 |
HYPOALBUMINAEMIA |
6 |
0.0008 |
| 347 |
HERPES SIMPLEX |
5 |
0.0008 |
| 348 |
HEPATITIS TOXIC |
2 |
0.0008 |
| 349 |
NON-HODGKIN'S LYMPHOMA |
1 |
0.0008 |
| 350 |
TRANSAMINASES INCREASED |
17 |
0.0008 |
| 351 |
RASH MACULO-PAPULAR |
17 |
0.0008 |
| 352 |
OBLITERATIVE BRONCHIOLITIS |
1 |
0.0008 |
| 353 |
LUNG OPACITY |
2 |
0.0008 |
| 354 |
HIRSUTISM |
1 |
0.0008 |
| 355 |
GLYCOSURIA |
1 |
0.0007 |
| 356 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 357 |
INFUSION SITE RASH |
1 |
0.0007 |
| 358 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 359 |
H1N1 INFLUENZA |
1 |
0.0007 |
| 360 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 361 |
ALVEOLITIS |
1 |
0.0007 |
| 362 |
NEUTROPENIC SEPSIS |
5 |
0.0007 |
| 363 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 364 |
NEUROLOGICAL SYMPTOM |
4 |
0.0007 |
| 365 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 366 |
BONE MARROW FAILURE |
14 |
0.0007 |
| 367 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
1 |
0.0007 |
| 368 |
GASTROINTESTINAL NECROSIS |
2 |
0.0007 |
| 369 |
LUNG INFILTRATION |
6 |
0.0007 |
| 370 |
BLOOD PARATHYROID HORMONE DECREASED |
1 |
0.0007 |
| 371 |
NEPHRECTOMY |
1 |
0.0007 |
| 372 |
BLOOD CULTURE POSITIVE |
2 |
0.0007 |
| 373 |
NEPHROGENIC SYSTEMIC FIBROSIS |
2 |
0.0007 |
| 374 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 375 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 376 |
FIBROSIS |
2 |
0.0006 |
| 377 |
MUCOSAL INFLAMMATION |
17 |
0.0006 |
| 378 |
NEURITIS |
1 |
0.0006 |
| 379 |
HAEMOLYSIS |
5 |
0.0006 |
| 380 |
MYELITIS |
1 |
0.0006 |
| 381 |
THERAPY PARTIAL RESPONDER |
10 |
0.0006 |
| 382 |
PULMONARY HAEMORRHAGE |
5 |
0.0006 |
| 383 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 384 |
HEPATITIS E |
1 |
0.0006 |
| 385 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
1 |
0.0006 |
| 386 |
HEPATITIS B REACTIVATION |
2 |
0.0006 |
| 387 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
6 |
0.0006 |
| 388 |
JC VIRUS INFECTION |
1 |
0.0006 |
| 389 |
CHOLESTASIS |
12 |
0.0006 |
| 390 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
0.0006 |
| 391 |
INTRA-UTERINE DEATH |
1 |
0.0006 |
| 392 |
LIVER ABSCESS |
2 |
0.0006 |
| 393 |
LYMPHOCYTE COUNT INCREASED |
2 |
0.0006 |
| 394 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 395 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
2 |
0.0006 |
| 396 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 397 |
CYTOLYTIC HEPATITIS |
2 |
0.0006 |
| 398 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 399 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 400 |
WOUND DEHISCENCE |
2 |
0.0006 |
| 401 |
TACHYPNOEA |
8 |
0.0006 |
| 402 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 403 |
DERMATITIS EXFOLIATIVE GENERALISED |
2 |
0.0006 |
| 404 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 405 |
BRONCHIOLITIS |
2 |
0.0006 |
| 406 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 407 |
PURPURA |
5 |
0.0006 |
| 408 |
CYTOMEGALOVIRUS TEST POSITIVE |
1 |
0.0006 |
| 409 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 410 |
LIVER TRANSPLANT |
2 |
0.0005 |
| 411 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 412 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 413 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 414 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 415 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 416 |
HAEMODYNAMIC INSTABILITY |
4 |
0.0005 |
| 417 |
MENOMETRORRHAGIA |
1 |
0.0005 |
| 418 |
HYPOREFLEXIA |
1 |
0.0005 |
| 419 |
ARTERIAL THROMBOSIS |
1 |
0.0005 |
| 420 |
VIRAL LOAD INCREASED |
2 |
0.0005 |
| 421 |
ATROPHY |
1 |
0.0005 |
| 422 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 423 |
ARTERIOSPASM CORONARY |
2 |
0.0005 |
| 424 |
RHINITIS |
4 |
0.0005 |
| 425 |
EYELID PAIN |
1 |
0.0005 |
| 426 |
ARTHRITIS BACTERIAL |
2 |
0.0005 |
| 427 |
EXTRAVASATION |
2 |
0.0005 |
| 428 |
HYPERURICAEMIA |
2 |
0.0005 |
| 429 |
MYELODYSPLASTIC SYNDROME |
7 |
0.0005 |
| 430 |
INSULIN RESISTANCE |
1 |
0.0005 |
| 431 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 432 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 433 |
LUNG ABSCESS |
1 |
0.0005 |
| 434 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 435 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 436 |
HYPERKINESIA |
1 |
0.0005 |
| 437 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
8 |
0.0005 |
| 438 |
NEUTROPHIL COUNT DECREASED |
19 |
0.0005 |
| 439 |
PLATELET COUNT DECREASED |
49 |
0.0005 |
| 440 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 441 |
INFUSION RELATED REACTION |
30 |
0.0005 |
| 442 |
PANCYTOPENIA |
25 |
0.0004 |
| 443 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 444 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1 |
0.0004 |
| 445 |
PNEUMONIA ASPIRATION |
11 |
0.0004 |
| 446 |
END STAGE RENAL DISEASE |
8 |
0.0004 |
| 447 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 448 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 449 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 450 |
TUBULOINTERSTITIAL NEPHRITIS |
8 |
0.0004 |
| 451 |
PULSE ABSENT |
2 |
0.0004 |
| 452 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 453 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 454 |
HAEMOGLOBIN DECREASED |
43 |
0.0004 |
| 455 |
SINUS BRADYCARDIA |
4 |
0.0004 |
| 456 |
SEPSIS |
46 |
0.0004 |
| 457 |
METRORRHAGIA |
7 |
0.0004 |
| 458 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
| 459 |
DERMAL CYST |
1 |
0.0004 |
| 460 |
HEPATOMEGALY |
4 |
0.0004 |
| 461 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 462 |
HAEMORRHAGE INTRACRANIAL |
6 |
0.0004 |
| 463 |
PROTEIN URINE PRESENT |
2 |
0.0004 |
| 464 |
HYDRONEPHROSIS |
3 |
0.0004 |
| 465 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
0.0004 |
| 466 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
| 467 |
TOXIC ENCEPHALOPATHY |
2 |
0.0004 |
| 468 |
ACIDOSIS |
3 |
0.0004 |
| 469 |
DISSEMINATED TUBERCULOSIS |
1 |
0.0004 |
| 470 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 471 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 472 |
ACUTE KIDNEY INJURY |
59 |
0.0004 |
| 473 |
PETECHIAE |
4 |
0.0004 |
| 474 |
FOLLICULITIS |
4 |
0.0004 |
| 475 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 476 |
FEBRILE NEUTROPENIA |
25 |
0.0004 |
| 477 |
AREFLEXIA |
1 |
0.0004 |
| 478 |
TREATMENT FAILURE |
31 |
0.0004 |
| 479 |
GINGIVITIS |
2 |
0.0004 |
| 480 |
LARGE INTESTINAL ULCER |
1 |
0.0004 |
| 481 |
HYPERAESTHESIA |
3 |
0.0004 |
| 482 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 483 |
DRUG LEVEL BELOW THERAPEUTIC |
2 |
0.0004 |
| 484 |
EMBOLISM |
3 |
0.0004 |
| 485 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 486 |
HAEMODIALYSIS |
3 |
0.0004 |
| 487 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 488 |
MENORRHAGIA |
7 |
0.0004 |
| 489 |
THERAPY NON-RESPONDER |
16 |
0.0004 |
| 490 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 491 |
IMMUNE THROMBOCYTOPENIC PURPURA |
1 |
0.0004 |
| 492 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
10 |
0.0004 |
| 493 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 494 |
HEPATITIS |
9 |
0.0004 |
| 495 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 496 |
MYOCARDIAL ISCHAEMIA |
4 |
0.0004 |
| 497 |
SUBDURAL HAEMATOMA |
5 |
0.0003 |
| 498 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 499 |
ENTEROCOLITIS |
2 |
0.0003 |
| 500 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 501 |
PYREXIA |
118 |
0.0003 |
| 502 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 503 |
PLEURISY |
2 |
0.0003 |
| 504 |
CEREBRAL HAEMORRHAGE |
12 |
0.0003 |
| 505 |
BRAIN HERNIATION |
1 |
0.0003 |
| 506 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 507 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 508 |
OSTEOMYELITIS |
6 |
0.0003 |
| 509 |
SQUAMOUS CELL CARCINOMA OF SKIN |
2 |
0.0003 |
| 510 |
ACNE |
25 |
0.0003 |
| 511 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 512 |
RESPIRATORY DISTRESS |
9 |
0.0003 |
| 513 |
DUODENITIS |
1 |
0.0003 |
| 514 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 515 |
BRAIN DEATH |
1 |
0.0003 |
| 516 |
OLIGURIA |
2 |
0.0003 |
| 517 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 518 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 519 |
ORTHOPNOEA |
1 |
0.0003 |
| 520 |
HYPOXIA |
11 |
0.0003 |
| 521 |
CUSHINGOID |
1 |
0.0003 |
| 522 |
PROCTALGIA |
2 |
0.0003 |
| 523 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0003 |
| 524 |
DRUG SPECIFIC ANTIBODY PRESENT |
2 |
0.0003 |
| 525 |
HYPOVENTILATION |
1 |
0.0003 |
| 526 |
RENAL FAILURE ACUTE |
13 |
0.0003 |
| 527 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 528 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 529 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 530 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 531 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 532 |
NEPHRITIS |
1 |
0.0003 |
| 533 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 534 |
HYPOTHERMIA |
3 |
0.0003 |
| 535 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 536 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 537 |
SUBARACHNOID HAEMORRHAGE |
3 |
0.0003 |
| 538 |
EPILEPSY |
9 |
0.0003 |
| 539 |
DRUG TOXICITY |
4 |
0.0003 |
| 540 |
CIRCULATORY COLLAPSE |
5 |
0.0003 |
| 541 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 542 |
BLOOD CREATININE INCREASED |
19 |
0.0003 |
| 543 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 544 |
GRANULOMA |
1 |
0.0003 |
| 545 |
DISSEMINATED INTRAVASCULAR COAGULATION |
4 |
0.0003 |
| 546 |
DUODENAL ULCER |
2 |
0.0003 |
| 547 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 548 |
PULMONARY TOXICITY |
2 |
0.0003 |
| 549 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 550 |
GLOSSITIS |
1 |
0.0003 |
| 551 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 552 |
LEUKOPENIA |
14 |
0.0003 |
| 553 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 554 |
FLUID OVERLOAD |
4 |
0.0003 |
| 555 |
C-REACTIVE PROTEIN INCREASED |
10 |
0.0003 |
| 556 |
OESOPHAGITIS |
3 |
0.0003 |
| 557 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 558 |
COMA |
13 |
0.0003 |
| 559 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 560 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 561 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 562 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 563 |
PRODUCT USE IN UNAPPROVED INDICATION |
64 |
0.0003 |
| 564 |
ACUTE MYELOID LEUKAEMIA |
4 |
0.0003 |
| 565 |
GOITRE |
1 |
0.0002 |
| 566 |
DEMYELINATION |
1 |
0.0002 |
| 567 |
FUNGAL INFECTION |
8 |
0.0002 |
| 568 |
CONGESTIVE CARDIOMYOPATHY |
1 |
0.0002 |
| 569 |
BRAIN OEDEMA |
3 |
0.0002 |
| 570 |
HYPERTENSION |
50 |
0.0002 |
| 571 |
RENAL INJURY |
7 |
0.0002 |
| 572 |
ABSCESS LIMB |
1 |
0.0002 |
| 573 |
LUNG NEOPLASM |
1 |
0.0002 |
| 574 |
ANURIA |
2 |
0.0002 |
| 575 |
WHITE BLOOD CELL COUNT DECREASED |
25 |
0.0002 |
| 576 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 577 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 578 |
NEUROTOXICITY |
4 |
0.0002 |
| 579 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 580 |
DYSMENORRHOEA |
3 |
0.0002 |
| 581 |
RENAL FAILURE |
30 |
0.0002 |
| 582 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 583 |
ASPARTATE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 584 |
EYE HAEMORRHAGE |
3 |
0.0002 |
| 585 |
HEPATOTOXICITY |
5 |
0.0002 |
| 586 |
CARDIOTOXICITY |
2 |
0.0002 |
| 587 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 588 |
GINGIVAL BLEEDING |
3 |
0.0002 |
| 589 |
HYPERGLYCAEMIA |
8 |
0.0002 |
| 590 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 591 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 592 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 593 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 594 |
HAEMOPTYSIS |
6 |
0.0002 |
| 595 |
ERYTHEMA MULTIFORME |
2 |
0.0002 |
| 596 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 597 |
CHILLS |
25 |
0.0002 |
| 598 |
STAPHYLOCOCCAL INFECTION |
7 |
0.0002 |
| 599 |
ALANINE AMINOTRANSFERASE INCREASED |
13 |
0.0002 |
| 600 |
DIALYSIS |
3 |
0.0002 |
| 601 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 602 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 603 |
CEREBRAL INFARCTION |
5 |
0.0002 |
| 604 |
ASCITES |
6 |
0.0002 |
| 605 |
LUNG DISORDER |
10 |
0.0002 |
| 606 |
RENAL IMPAIRMENT |
17 |
0.0002 |
| 607 |
MUCOUS STOOLS |
1 |
0.0002 |
| 608 |
COLON CANCER |
3 |
0.0002 |
| 609 |
ANEURYSM |
1 |
0.0002 |
| 610 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 611 |
ERYSIPELAS |
1 |
0.0002 |
| 612 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 613 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 614 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 615 |
CACHEXIA |
1 |
0.0002 |
| 616 |
INFLAMMATION |
10 |
0.0002 |
| 617 |
RENAL DISORDER |
9 |
0.0002 |
| 618 |
LUNG INFECTION |
3 |
0.0002 |
| 619 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 620 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 621 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 622 |
RENAL PAIN |
2 |
0.0002 |
| 623 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
9 |
0.0002 |
| 624 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 625 |
ANAL ABSCESS |
1 |
0.0002 |
| 626 |
HYDROCEPHALUS |
1 |
0.0002 |
| 627 |
WOUND INFECTION |
2 |
0.0002 |
| 628 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0002 |
| 629 |
MELAENA |
4 |
0.0002 |
| 630 |
CARDIAC ARREST |
15 |
0.0002 |
| 631 |
HYPERKERATOSIS |
1 |
0.0002 |
| 632 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 633 |
LIVER DISORDER |
8 |
0.0002 |
| 634 |
COAGULOPATHY |
3 |
0.0002 |
| 635 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 636 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 637 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 638 |
RESPIRATORY FAILURE |
13 |
0.0002 |
| 639 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 640 |
HEPATIC ENZYME INCREASED |
12 |
0.0002 |
| 641 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 642 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 643 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 644 |
HYPERVENTILATION |
1 |
0.0002 |
| 645 |
VASCULITIS |
2 |
0.0002 |
| 646 |
LYMPHADENOPATHY |
6 |
0.0002 |
| 647 |
DISEASE PROGRESSION |
20 |
0.0002 |
| 648 |
ODYNOPHAGIA |
1 |
0.0002 |
| 649 |
RASH ERYTHEMATOUS |
8 |
0.0002 |
| 650 |
URTICARIA |
28 |
0.0002 |
| 651 |
HEPATITIS B |
1 |
0.0002 |
| 652 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 653 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 654 |
CHOLANGITIS |
1 |
0.0002 |
| 655 |
THROMBOCYTOPENIA |
18 |
0.0002 |
| 656 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 657 |
HAEMATEMESIS |
4 |
0.0002 |
| 658 |
PULMONARY OEDEMA |
7 |
0.0002 |
| 659 |
ENTERITIS |
1 |
0.0002 |
| 660 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 661 |
MYDRIASIS |
2 |
0.0002 |
| 662 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 663 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 664 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
6 |
0.0002 |
| 665 |
VIRAL INFECTION |
5 |
0.0002 |
| 666 |
MENINGITIS |
1 |
0.0001 |
| 667 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 668 |
JAUNDICE |
4 |
0.0001 |
| 669 |
STOMATITIS |
9 |
0.0001 |
| 670 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 671 |
TASTE DISORDER |
3 |
0.0001 |
| 672 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 673 |
PNEUMONITIS |
4 |
0.0001 |
| 674 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 675 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 676 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 677 |
PERITONITIS |
3 |
0.0001 |
| 678 |
DIABETES MELLITUS |
11 |
0.0001 |
| 679 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 680 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 681 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 682 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 683 |
LYMPHOPENIA |
2 |
0.0001 |
| 684 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 685 |
BRONCHOSPASM |
2 |
0.0001 |
| 686 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 687 |
CONVULSION |
8 |
0.0001 |
| 688 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 689 |
ALTERED STATE OF CONSCIOUSNESS |
3 |
0.0001 |
| 690 |
INFECTION |
20 |
0.0001 |
| 691 |
TOXICITY TO VARIOUS AGENTS |
23 |
0.0001 |
| 692 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 693 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 694 |
ORAL PAIN |
3 |
0.0001 |
| 695 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 696 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 697 |
HEPATIC FAILURE |
4 |
0.0001 |
| 698 |
BRADYCARDIA |
7 |
0.0001 |
| 699 |
THERAPEUTIC RESPONSE DECREASED |
8 |
0.0001 |
| 700 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 701 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 702 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 703 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 704 |
GINGIVAL PAIN |
1 |
0.0001 |
| 705 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 706 |
CARDIAC FAILURE |
10 |
0.0001 |
| 707 |
TACHYCARDIA |
11 |
0.0001 |
| 708 |
PRODUCT USE ISSUE |
23 |
0.0001 |
| 709 |
LIVER INJURY |
3 |
0.0001 |
| 710 |
ALOPECIA |
24 |
0.0001 |
| 711 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 712 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 713 |
HEMIPLEGIA |
1 |
0.0001 |
| 714 |
CANDIDA INFECTION |
2 |
0.0001 |
| 715 |
HAEMATURIA |
4 |
0.0001 |
| 716 |
DRUG RESISTANCE |
3 |
0.0001 |
| 717 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 718 |
VAGINAL HAEMORRHAGE |
5 |
0.0001 |
| 719 |
RHEUMATOID ARTHRITIS |
13 |
0.0001 |
| 720 |
HYPERKALAEMIA |
4 |
0.0001 |
| 721 |
GROIN PAIN |
1 |
0.0001 |
| 722 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 723 |
CARDIAC FAILURE CONGESTIVE |
9 |
0.0001 |
| 724 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
0.0001 |
| 725 |
HYPOTENSION |
22 |
0.0001 |
| 726 |
UNDERDOSE |
8 |
0.0001 |
| 727 |
SKIN LESION |
3 |
0.0001 |
| 728 |
ANAPHYLACTIC REACTION |
6 |
0.0001 |
| 729 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 730 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 731 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0001 |
| 732 |
APPENDICITIS |
1 |
0.0001 |
| 733 |
HYPONATRAEMIA |
6 |
0.0001 |
| 734 |
PHOTOPHOBIA |
2 |
0.0001 |
| 735 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 736 |
PROTEINURIA |
2 |
0.0001 |
| 737 |
ATELECTASIS |
1 |
0.0001 |
| 738 |
DYSSTASIA |
3 |
0.0001 |
| 739 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 740 |
ORAL HERPES |
2 |
0.0001 |
| 741 |
PREGNANCY |
2 |
0.0001 |
| 742 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 743 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 744 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 745 |
PNEUMONIA |
31 |
0.0001 |
| 746 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 747 |
AGITATION |
7 |
0.0001 |
| 748 |
RASH PRURITIC |
5 |
0.0001 |
| 749 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 750 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 751 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 752 |
DENTAL CARIES |
1 |
0.0001 |
| 753 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 754 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 755 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 756 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 757 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 758 |
NEUTROPENIA |
12 |
0.0001 |
| 759 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 760 |
MYOCARDITIS |
1 |
0.0001 |
| 761 |
THROMBOSIS |
7 |
0.0001 |
| 762 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 763 |
GENERAL PHYSICAL HEALTH DETERIORATION |
10 |
0.0001 |
| 764 |
EYELID OEDEMA |
1 |
0.0001 |
| 765 |
CAESAREAN SECTION |
1 |
0.0001 |
| 766 |
BONE PAIN |
5 |
0.0001 |
| 767 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 768 |
CHOLECYSTITIS |
1 |
0.0001 |
| 769 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 770 |
ABDOMINAL PAIN UPPER |
17 |
0.0001 |
| 771 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 772 |
URINARY TRACT INFECTION |
14 |
0.0001 |
| 773 |
CYTOPENIA |
1 |
0.0001 |
| 774 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 775 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 776 |
CARDIOMEGALY |
1 |
0.0001 |
| 777 |
CYST |
1 |
0.0001 |
| 778 |
ILEUS |
1 |
0.0001 |
| 779 |
HALLUCINATION |
6 |
0.0001 |
| 780 |
ANAEMIA |
15 |
0.0001 |
| 781 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 782 |
THERAPY CESSATION |
4 |
0.0001 |
| 783 |
GENITAL HAEMORRHAGE |
1 |
0.0001 |
| 784 |
ANOREXIA |
1 |
0.0001 |
| 785 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 786 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 787 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 788 |
MYALGIA |
13 |
0.0001 |
| 789 |
DISORIENTATION |
3 |
0.0001 |
| 790 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 791 |
SOMNOLENCE |
15 |
0.0001 |
| 792 |
OEDEMA |
4 |
0.0001 |
| 793 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 794 |
RASH |
32 |
0.0001 |
| 795 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 796 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 797 |
DIVERTICULITIS |
2 |
0.0001 |
| 798 |
FEELING COLD |
2 |
0.0001 |
| 799 |
INFLUENZA |
8 |
0.0001 |
| 800 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 801 |
MASS |
1 |
0.0001 |
| 802 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 803 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 804 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 805 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 806 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 807 |
GASTROENTERITIS |
1 |
0.0001 |
| 808 |
CONFUSIONAL STATE |
11 |
0.0001 |
| 809 |
ANGIOEDEMA |
3 |
0.0001 |
| 810 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 811 |
THROAT IRRITATION |
3 |
0.0001 |
| 812 |
EPISTAXIS |
5 |
0.0001 |
| 813 |
CONDITION AGGRAVATED |
20 |
0.0001 |
| 814 |
OEDEMA PERIPHERAL |
8 |
0.0001 |
| 815 |
HYPOKALAEMIA |
3 |
0.0001 |
| 816 |
OVERDOSE |
14 |
0.0001 |
| 817 |
LYMPHOMA |
1 |
0.0001 |
| 818 |
ANKLE FRACTURE |
1 |
0.0001 |
| 819 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 820 |
CYANOSIS |
1 |
0.0001 |
| 821 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 822 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 823 |
CONTUSION |
6 |
0.0001 |
| 824 |
NIGHT SWEATS |
2 |
0.0001 |
| 825 |
OSTEONECROSIS |
2 |
0.0001 |
| 826 |
EYE DISORDER |
2 |
0.0001 |
| 827 |
HEART RATE INCREASED |
6 |
0.0001 |
| 828 |
DRUG INEFFECTIVE |
79 |
0.0001 |
| 829 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 830 |
CELLULITIS |
3 |
0.0001 |
| 831 |
CHEST PAIN |
11 |
0.0001 |
| 832 |
OFF LABEL USE |
52 |
0.0001 |
| 833 |
FACE OEDEMA |
1 |
0.0001 |
| 834 |
RASH MACULAR |
2 |
0.0001 |
| 835 |
AMENORRHOEA |
1 |
0.0001 |
| 836 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 837 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 838 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 839 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 840 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 841 |
DYSURIA |
2 |
0.0001 |
| 842 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 843 |
NECK PAIN |
3 |
0.0001 |
| 844 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 845 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 846 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 847 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 848 |
HEADACHE |
33 |
0.0001 |
| 849 |
HAEMORRHOIDS |
1 |
0.0001 |
| 850 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 851 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 852 |
IRRITABILITY |
3 |
0.0000 |
| 853 |
DYSKINESIA |
2 |
0.0000 |
| 854 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 855 |
ERYTHEMA |
10 |
0.0000 |
| 856 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 857 |
DERMATITIS |
1 |
0.0000 |
| 858 |
ABDOMINAL PAIN |
11 |
0.0000 |
| 859 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 860 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 861 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 862 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 863 |
VOMITING |
21 |
0.0000 |
| 864 |
CHROMATURIA |
1 |
0.0000 |
| 865 |
SEIZURE |
5 |
0.0000 |
| 866 |
DRUG INTOLERANCE |
4 |
0.0000 |
| 867 |
LOCALISED INFECTION |
1 |
0.0000 |
| 868 |
NEURALGIA |
1 |
0.0000 |
| 869 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 870 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 871 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 872 |
BLOOD PRESSURE INCREASED |
6 |
0.0000 |
| 873 |
DYSPNOEA |
22 |
0.0000 |
| 874 |
DIARRHOEA |
25 |
0.0000 |
| 875 |
HAEMATOMA |
1 |
0.0000 |
| 876 |
DIPLOPIA |
1 |
0.0000 |
| 877 |
HAEMORRHAGE |
4 |
0.0000 |
| 878 |
DEAFNESS |
1 |
0.0000 |
| 879 |
GASTRITIS |
1 |
0.0000 |
| 880 |
PANCREATITIS |
2 |
0.0000 |
| 881 |
DRUG INTERACTION |
6 |
0.0000 |
| 882 |
EAR INFECTION |
1 |
0.0000 |
| 883 |
PAIN |
23 |
0.0000 |
| 884 |
MOOD ALTERED |
1 |
0.0000 |
| 885 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 886 |
ANGINA PECTORIS |
1 |
0.0000 |
| 887 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 888 |
CATARACT |
2 |
0.0000 |
| 889 |
APHASIA |
1 |
0.0000 |
| 890 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 891 |
HOSPITALISATION |
5 |
0.0000 |
| 892 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 893 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 894 |
WEIGHT DECREASED |
9 |
0.0000 |
| 895 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 896 |
COUGH |
9 |
0.0000 |
| 897 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 898 |
CYSTITIS |
1 |
0.0000 |
| 899 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 900 |
RHINORRHOEA |
2 |
0.0000 |
| 901 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 902 |
SWELLING FACE |
2 |
0.0000 |
| 903 |
IMPAIRED HEALING |
1 |
0.0000 |
| 904 |
LIP SWELLING |
1 |
0.0000 |
| 905 |
GAIT INABILITY |
1 |
0.0000 |
| 906 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 907 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 908 |
ASTHENIA |
11 |
0.0000 |
| 909 |
VISION BLURRED |
4 |
0.0000 |
| 910 |
ARTHRALGIA |
12 |
0.0000 |
| 911 |
DELIRIUM |
1 |
0.0000 |
| 912 |
COVID-19 |
5 |
0.0000 |
| 913 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 914 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 915 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 916 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 917 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 918 |
DYSARTHRIA |
1 |
0.0000 |
| 919 |
COLITIS |
1 |
0.0000 |
| 920 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 921 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 922 |
DECREASED APPETITE |
6 |
0.0000 |
| 923 |
BACK PAIN |
6 |
0.0000 |
| 924 |
PALPITATIONS |
3 |
0.0000 |
| 925 |
NAUSEA |
20 |
0.0000 |
| 926 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 927 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 928 |
BLINDNESS |
1 |
0.0000 |
| 929 |
TREMOR |
4 |
0.0000 |
| 930 |
HYPOACUSIS |
1 |
0.0000 |
| 931 |
DEATH |
20 |
0.0000 |
| 932 |
BALANCE DISORDER |
2 |
0.0000 |
| 933 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 934 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 935 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 936 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 937 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 938 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 939 |
SWELLING |
2 |
0.0000 |
| 940 |
DYSPHAGIA |
2 |
0.0000 |
| 941 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 942 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 943 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 944 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 945 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 946 |
AGGRESSION |
1 |
0.0000 |
| 947 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 948 |
SINUSITIS |
2 |
0.0000 |
| 949 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 950 |
ILLNESS |
2 |
0.0000 |
| 951 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 952 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 953 |
MEDICATION ERROR |
1 |
0.0000 |
| 954 |
BLISTER |
1 |
0.0000 |
| 955 |
EYE PAIN |
1 |
0.0000 |
| 956 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 957 |
HERPES ZOSTER |
1 |
0.0000 |
| 958 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 959 |
NASAL CONGESTION |
1 |
0.0000 |
| 960 |
DISCOMFORT |
1 |
0.0000 |
| 961 |
MUSCLE SPASMS |
3 |
0.0000 |
| 962 |
FEELING HOT |
1 |
0.0000 |
| 963 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 964 |
PRURITUS |
6 |
0.0000 |
| 965 |
DEHYDRATION |
2 |
0.0000 |
| 966 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 967 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 968 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 969 |
FATIGUE |
11 |
0.0000 |
| 970 |
MALAISE |
6 |
0.0000 |
| 971 |
BRONCHITIS |
1 |
0.0000 |
| 972 |
WEIGHT INCREASED |
3 |
0.0000 |
| 973 |
PARAESTHESIA |
2 |
0.0000 |
| 974 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 975 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 976 |
INSOMNIA |
3 |
0.0000 |
| 977 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 978 |
ADVERSE EVENT |
1 |
0.0000 |
| 979 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 980 |
ANXIETY |
3 |
0.0000 |
| 981 |
MIGRAINE |
1 |
0.0000 |
| 982 |
FLUSHING |
1 |
0.0000 |
| 983 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 984 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 985 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 986 |
DEPRESSION |
2 |
0.0000 |
| 987 |
FEELING ABNORMAL |
2 |
0.0000 |
| 988 |
HYPOAESTHESIA |
1 |
0.0000 |
| 989 |
CONSTIPATION |
1 |
0.0000 |
| 990 |
DIZZINESS |
1 |
0.0000 |